Emergent Biosolutions LLC – FDA 483, Dec 21, 2017
Emergent BioDefense Operations Lansing LLC, a manufacturer of vaccine drug substance in Canton, MA, was cited for significant quality system deficiencies during an FDA inspection. Observations included failures in biological product deviation reporting, incomplete investigations, untimely corrective actions, and inadequate environmental controls. The firm also had issues with facility maintenance, equipment qualification, and documentation practices, indicating a broad range of non-compliance.
ID · 878d4eff-86a9-4383-84fd-d7d5a3ccde2f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.